NEXGEN BLENDS Trademark
Serial Number: 98365218
NEXGEN BLENDS is a trademark filed by
NATURE'S TALE LLC
on January 19, 2024. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently pending registration.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Michael B. Chesal Peretz Chesal & Herrmann, P.L.
1 S.E. 3rd Avenue, Suite 1820
Miami, FL 33131
United States
Trademark Details
Filing Date
January 19, 2024
Registration Date
Not Registered
Published for Opposition
May 19, 2026
Goods & Services
Dietary and nutritional supplements; Vitamin supplements; all the foregoing goods are intended solely for human consumption
Filing History
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 19, 2026 NPUB
PUBLISHED FOR OPPOSITION
May 19, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 13, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 22, 2026 CNSA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 15, 2026 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 17, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 17, 2025 GNSL
SUSPENSION LETTER WRITTEN
Jul 17, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 16, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 16, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 16, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 16, 2025 GNFN
FINAL REFUSAL E-MAILED
Apr 16, 2025 GNFR
FINAL REFUSAL WRITTEN
Apr 16, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 19, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 19, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 19, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Nov 19, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Nov 19, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 19, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 19, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 19, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 14, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 18, 2024 NWOS
NEW APPLICATION ENTERED
Jan 19, 2024 NWAP
